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Abstract
Objective: Cleft lip and palate is a congenital facial malformation with an established treatment protocol. Mixed 
dentition period is the best moment for correct maxillary bone defect with an alveoloplasty.  The aim of this surgi-
cal procedure is to facilitate dental eruption, re-establish maxillary arch, close any oro-nasal communication, give 
support to nasal ala, and in some cases allow dental rehabilitation with osteointegrated implants. 
Study design: Twenty cleft patients who underwent secondary alveoloplasty were included. In 10 of them autog-
enous bone graft were used and in other 10 autogenous bone and platelet-rich plasma (PRP) obtained from autog-
enous blood. Bone formation was compared by digital orthopantomography made on immediate post-operatory 
and 3 and 6 months after the surgery. 
Results: No significant differences were found between both therapeutic groups on bone regeneration. 
Conclusion: We do not find justified the use of PRP for alveoloplasty in cleft patients’ treatment protocol.
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Introduction 
Cleft lip and palate is the most prevalent congenital fa-
cial malformation. It is present in 1 of 500-1000 live-
born babies, with several severity levels. Treatment 
sequence is widely accepted and includes alveoloplasty 
at 7-9 years in order to correct maxillary bone defect. 
Since Boyne et al. (1) popularized secondary alveolo-
plasty in cleft patients (1), many studies have been pub-
lished about ideal timing, surgical technique, radiologi-
cal evaluation, orthodontic treatment, bone distraction 
or rehabilitation with dental implants (1,2).  
Alveoloplasty may be performed primary before 2 
years. After that moment it is called secondary alveo-
loplasty. If it is done between 2-5 years (early alveolo-
plasty), after 12 years (late alveoloplasty) and between 
5-12 years it is called intermediate or real secondary al-
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veoloplasty. Even it could be differentiated within real 
secondary alveoloplasty between early secondary if it is 
done before central incisor eruption (before 9 years) and 
late secondary alveoloplasty if is done when canine root 
is formed between 1/4 and 2/3 (9-11 years). It was al-
ready published that timing of the operation is a critical 
factor. When alveoloplasty is performed before canine 
eruption, successful rate is higher and is comparable 
independently of the cleft severity. When alveoloplasty 
is done late (after canine eruption) successful rate de-
creases and cleft severity influences in a negative man-
ner on procedure success (3).     
The preferable moment for bone graft in alveoloar cleft 
is in the period of mixed dentition when canine root is 
formed between ¼ and ½ around 7-9 years. Reconstruc-
tion is done with autologous bone graft and the aim of 
the procedure is to close oro-nasal communication, per-
mit canine eruption, give bone support to adjacent teeth, 
facilitate orthodontic treatment, contribute to stability 
and continuity to maxillary arch (avoiding collapse of 
structures previously expanded by orthodontics), give 
support to nasal ala and allow dental rehabilitation with 
osteointegrated dental implants when necessary (2).
By the other hand, platelet-rich plasma (PRP) is defined 
as high concentration of autologous platelets in a small 
volume of autologous plasma (4). Platelets contained 
in this autologous concentrate release their alpha gra-
nules during the first minutes of their activation. These 
contains molecules as PDGF, TGF-B, IGF, VEGF and 
others that stimulate proliferation, chemiotaxis and dif-
ferentiation of osteogenesis essential cells accelerating 
the process. During the last 20 years, PRP has been 
used in many applications such as accelerate burn hea-
ling, chronic ulcers, knee ligament repair, hemostatic or 
retinal neurogenesis. Many works have show by rand-
omized clinical trials its utility in soft tissues regenera-
tion (5-8). The objective of this study is to evaluate the 
usefulness of mixing PRP with autologous bone graft in 
bone regeneration of alveolar cleft compared to autolo-
gous bone without PRP. 
Patients and Methods
During the period 1999-2007, 64 alveoloplasties were 
performed in the Department of Oral and Maxillofacial 
Surgery in A Coruña University Hospital. 38 of these 
were secondary alveoloplasties (before canine erup-
tion). Twenty patients who underwent secondary bone 
graft in the alveolar cleft were included in this study. 
In the first 10 patients autologous bone graft (iliac bone 
in most of them) and 1 cc of PRP was used. PRP was 
obtained from a self donation done the same day of the 
operation. In the other 10 patients the bone grafting was 
done without PRP.  
In our protocol, radiographic control is done from 5 
years old in order to determine the best moment for the 
surgery. Preoperatory orthodontic treatment is done 
with the aim of expanding maxillary arch, teeth align-
ment and make a gap for the bone graft. Orthodontics 
continues for 8-12 weeks after the alveoloplasty. If the 
orthodontic arch wire crosses the alveolar cleft, it should 
be removed just before surgery. In bilateral cleft, the or-
thodontic arch is placed back after the procedure in the 
operating room and maintained for 8 weeks in order to 
contribute to premaxilla and bone graft stability. Can-
cellous iliac bone was the used graft in most of cases. 
Root development is evaluated radiographically (peri-
apical radiography or orthopantomography) to deter-
mine the appropriate moment for the alveoloplasty. All 
lip and palate cleft patients were candidates to undergo 
a secondary alveoloplasty. Naso-tracheal intubation by 
the non-affected side was used in unilateral clefts and 
oro-tracheal in bilateral cleft patients. Prophylactic ad-
ministration of Amoxicillin-clavulanic acid was done 
half an hour before the surgery and antibiotic is main-
tained for 8 days after the operation.  
Two surgical teams work at the same time, one obtai-
ning the iliac crest graft and the other performing the 
alveoloplasty itself. No drain is used in any surgical 
field and all patients were operated by the same surgeon 
(JLC). This surgeon prepares the surgical field in the 
alveolar cleft, closes oro-nasal communication if ex-
ists, and performs the alveoloplasty itself with the bone 
obtained by the other surgical team. Boyne and Sands 
(1) described the procedure of grafting the cancellous 
iliac bone on the maxillary defect. The day of the opera-
tion 1cc of PRP was obtained from 10 cc of whole blood 
drawn from the patient. The Department of Hematology 
obtained the PRP by a double centrifuge of the speci-
men. In the operating room calcium chlorate was added 
and the product is incubated for 3 minutes at 37ºC until 
a bright red clot is obtained. Cancellous bone and PRP 
are mixed and the malleable material is inserted into the 
alveolar cleft. Gingival mucoperiosteal flaps should be 
closed tension-free. Periosteal incisions should be done 
if necessary. Closure is done with resorbable 4/0 mate-
rial. Margins of the palatal flaps on the oro-nasal fistula 
course are refreshed, granulation tissue removed and 
watertight closure with resorbable 4/0 material is done. 
Both vestibular flaps are sutured between them along 
the course of the original fistula and to the palatal flaps 
on the alveolar ridge over the cleft area. Patients were 
discharged 24-48 hours after the surgery.
Bone formation on alveolar cleft was registered by dig-
ital orthopantomography obtained on immediate post-
operatory, at 3 and 6 months after the surgery. Bone in-
crease was measured in a subjective but blind manner, 
by a gradual 1-4 scale (1 minimum bone formation, 4 
maximum bone formation) scored by four blind obser-
vers, all of them experts surgeons from the Department 
of Oral and Maxillofacial Surgery. Previous calibration 
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process was needed between all the observers, in order 
to assess the agreement grade. Computerized tomogra-
phy (CT) and biopsy were rejected because of economic 
and ethical reasons.
Results
Orthopantomography mean score was obtained from 
each of the 20 patients in the immediate post-operatory 
and 3 and 6 months after the surgery. Bone increase be-
tween third and sixth month was calculated. The first 
group (PRP group) consisted on 6 men and 4 women 
with a mean age of 8.7 years. They were 7 unilateral 
and 3 bilateral clefts. In 1 case was employed tibial bone 
graft, in 2 cases the donor area was mandibular sym-
physis and iliac crest in the other 7 cases. 
The second group (non-PRP group) was composed by 
7 men and 3 women with an average age of 9.1 years. 
Seven patients were unilateral cleft and three were bi-
lateral. Iliac bone graft was used in all of them. Mean 
score of bone formation in each patient in the immedi-
ate post-operatory and 3 and 6 months after the surgery 
is recorded in table 1. Bone increase between third and 
sixth month is observed too.   
Statistical analysis was done with the Mann-Witney test 
and p-value of less than 0.05 was considered statisti-
cally significant. No statistically significant differences 
in bone formation were found between both groups in 
early post-operatory (with PRP 1,32+-0,38 and with-
out PRP 1,89+-0,76), neither after 3 months (with PRP 
2,2+-0,7 and without PRP 2,64+-0,76) or after 6 months 
(with PRP 2,43+-0,6 and without PRP 3,17+-0,866). 
No statistically significant differences in bone increase 
in the period 0-3 months (with PRP 0,88+-0,77 and 
without PRP 0,75+-1,1) or the period 3-6 months (with 
PRP 0,23+-0,5 and without PRP 0,53+-0,64), or in 0-6 
months (with PRP 1,1+-0,8 and without PRP 1,2+-1,1) 
were found too.           
Discussion 
PRP use in oral surgery was initially based on wound 
healing acceleration due to growth factor release from 
activated platelet (6). Eighty eight autologous grafts in 
human mandibles were done in one of most important 
initial studies. In half of them PRP was added, and 
PATIENT Sex Age imme-diate 3 months 6months 3-6 months
Uni-
bilat bone PRP
1 M 7y2m 1 2 3,3 1,3 U iliac YES
2 F 7y8m 1 3 3,3 1,3 U iliac YES
3 F 9y6m 1,3 1,7 1,7 0 U iliac YES
4 M 8y10m 1,3 1,7 2 0,3 U iliac YES
5 M 8y9m 1,3 1,7 1,7 0 U tibial YES
6 F 7y11m 2 2,3 2,3 0 B symphysis YES
7 M 7y10m 1,3 3,7 3 -0,7 B symphysis YES
8 F 9y 1 1,3 2 0,7 U iliac YES
9 M 8y9m 2 2,3 2,3 0 U iliac YES
10 M 10y7m 1 2,3 2,7 0,3 B iliac YES
11 M 6y11m 3,3 2,7 3,3 0,6 U iliac NO
12 F 9y3m 2,7 1,3 1,7 0,3 U iliac NO
13 F 10y2m 1,7 3,7 3 -0,7 U iliac NO
14 M 8y3m 1,3 2 3,3 1,3 U iliac NO
15 M 8y 1,3 2 1,7 -0,3 B iliac NO
16 M 8y7m 2 2,3 3 1 B iliac NO
17 M 11y6m 1 2,7 4 1,3 U iliac NO
18 F 7y2m 2,3 3 3,7 0,7 U iliac NO
19 M 8y11m 1 3 4 1 B iliac NO
20 F 12y10m 2,3 3,7 4 0,33 U iliac NO
TOTAL 33,1 48,4 56 7,4
MEAN 8,8years 1,655 2,42 2,8 0,37
Table 1. Patients classification by age, sex, uni or bilateral cleft, kind of bone graft used, PRP addition or not, and their score 
on bone formation scale in immediate post-operatory, at 3 months, at 6 moths, and the increase between 3-6 months. 
M: male; F: female; m: months; U: unilateral; B: bilateral.
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higher bone maturity and density than in control group 
was showed radiographically and histomorphometri-
cally (7,9). Many works have supported the use of PRP 
in oral surgery, being accepted its utility in periodontal 
and soft tissue regeneration (4,6-8). But other authors 
argue the lack of scientific evidence for defending the 
use of PRP in bone regeneration and recommend the 
surgeon to maintain a critical mind (10-13). In one of 
the most important reported metaanalysis the absence 
of reliable evidence of any active agent such as bone-
promoter molecules or PRP in dental implants treat-
ment is remarked (11).  Beneficial effects of PRP in peri-
odontal defects have been probed recently. But efficacy 
evidence in sinus lift remains weak and these authors 
can not conclude any other PRP application in odontol-
ogy based on their reviewed literature (12). 
Boyne and Sands (1) started particulated cancellous 
bone grafting on alveolar clefts during mixed denti-
tion combined with orthodontic treatment in order to 
contribute to maxillary stability, allow dental eruption 
thought the grafted bone and facilitate posterior ortho-
dontic treatment. Most of the authors agree that second-
ary bone grafting during mixed dentition period does 
not affect significantly to facial growth, because at the 
8th year of life most of the maxillary development has 
already happened. Surgical indication was done in ac-
cordance with the orthodontist, based on growth, or-
thodontic and prosthodontic criteria. An only surgeon 
(JLC) operated all patients following the same surgical 
technique. Iliac crest is the preferred donor site in this 
kind of patients. Other donor sites as tibia or chin are 
only chosen on small size defects, because of the lim-
ited amount of available bone, on an attempt of avoiding 
temporal sequela after harvesting iliac crest grafts. All 
mucoperiosteal flaps were designed to cover the bone 
graft with attached gum. Some authors recommend 
PRP use in the alveoloplasties because it facilitates 
bone regeneration (2) and soft tissue healing (5). Other 
works do not find any long term advantage in use PRP 
mixed with autologous bone (11).  
Secondary alveoloplasty efficacy was supported by au-
thors as Matsui et al. (14) who found that most of cleft 
patients in his serie had spontaneous canine eruption af-
ter real secondary alveoloplasty. Just very few of them 
needed orthodontic traction. He found relation between 
width bone defect on nasal side and canine surgical 
exposure requirement. The way of checking the bone 
increase remains controversial. Van der Meij et al. (15) 
proved by CT the remaining grafted bone 1 year after 
the surgery. His work does not find significant differ-
ences between late and early secondary alveoloplasty. 
But a lesser degree of bone persistence on bilateral cleft 
(45%) than in unilateral cleft (70%) was showed. In spite 
of that, bone amount was enough for canine eruption.   
Performing secondary alveoloplasty, Trindade et al. (16) 
gets 95% success rate in unilateral clefts and defends 
periapical radiography to confirm the success of the 
grafted bone. However Feichtinger et al. (17) making CT 
3D preoperatively and 1, 2 and 3 years postoperatively, 
describes a bone loss of 49.5% on the bucco-palatal di-
mension of the bone transplant during the first year, and 
remaining constant the following 2 years. He rejects 
conventional two-dimension radiographs to quantify 
bone loss. He supports a higher success rate when the 
gap is closed orthodontically in a short period of time. 
Oyama et al. (2) compares tertiary alveoloplasty in 7 
cleft patients using iliac crest with PRP and another 7 
without PRP. He uses CT 3D before and 6 months after 
the surgery and proves than PRP group formed more 
bone. He agrees that there is no widely accepted meth-
od for bone grafting quantification and suggests that 
bone formation quantity and quality should be tested. 
We ruled out bone biopsy and CT before and after the 
surgery because of the radiation exposure in growing 
period patients. Lee et al. (18) compares 2 alveoloplasty 
groups of 35 patients each one with and without PRP. 
He came to conclusion that PRP is not enough to avoid 
alveolar graft resorption in secondary alveoloplasty. 
He applies specific software to evaluate bone forma-
tion through sample dental radiographies.  We tried to 
measure bone increase using a computer programme in 
conjunction with the Radiology Department.  An adja-
cent tooth was used as a correction factor that remains 
constant in its radiopacity in order to compare formed 
bone. But the complexity of the anatomical area, erupt-
ing teeth and orthodontic appliances prevented to ob-
tain predictable results, so the study was abandoned. 
Cone Beam Computed Tomography (CBCT) is gaining 
ground in odontology and maxillofacial surgery (19). Its 
high imaging quality and anatomical precision in pre-
maxilla (20) would be very useful in a work like this to 
evaluate bone density. But nowadays economic cost is 
its great handicap. This study was carried out in a pub-
lic hospital, and it is impossible to achieve this kind of 
diagnostic imaging there.   
Conclusions
Alveoloplasty constitutes an excellent surgical method 
for correcting alveolar cleft. It allows closing oro-nasal 
fistula, preserving dental health, and performing a cor-
rect orthodontic treatment. We consider acceptable our 
results, agree with reviewed literature. Wide base muco-
periosteal gingival flaps have excellent vascularization 
and allow a tension-free closure on the grafted alveolus. 
Our design modification let raise an easy flap with op-
timal mobility. It does not produce papillar or vestibu-
lar sulcus modifications and allows healthy periodon-
tal gum for teeth eruption and successful orthodontic 
treatment. We do not find evidence for PRP application 
to facilitate bone formation in secondary alveoloplasty 
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of cleft patients, although its consistency makes easier 
handling and packing the graft. Our serie is too small to 
obtain conclusive results. More prospective randomized 
controlled studies are needed to achieve definitive data 
against or in favour of PRP use on alveoloplasty of 
cleft patients. There are still two important points with 
no agreement. The first one is to establish a standard 
method of obtaining PRP so that its properties were 
comparable in different studies. The second point is to 
accord an accepted way to quantify bone increase after 
the alveoloplasty.  
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